Skip to content
healthcare.dev

Orgovyx

NDC 72974-120, relugolix, tablet, film coated, from Sumitomo Pharma America, Inc..

Product NDC
72974-120
Status
Listed
Labeler
Sumitomo Pharma America, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214621
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72974-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RELUGOLIX120 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
72974-120-017297401200130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01)
72974-120-957297401209516 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95)
72974-120-977297401209730 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/077a92f6-9f1b-479a-87c7-c92b5db6aa9c

Use it

Look up 72974-120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72974-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72974-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.